CANCER VACCINE PLUS PD-1 BLOCKADE PROMOTES INFILTRATION OF MELANOMA METASTASES BY VACCINE-INDUCED T LYMPHOCYTES

被引：0
|
作者：
Tran, Christine [1 ]
Schwartzman, Gabrielle [1 ]
Olson, Walter [1 ]
Smith, Kelly [1 ]
Bryant, Jennifer [1 ]
Slingluff, Craig [1 ]
机构：
[1] Univ Virginia, Charlottesville, VA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.1474
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1474
引用
收藏
页码：A1533 / A1533
页数：1
相关论文
共 50 条
  • [1] Cancer Vaccine Plus Intratumoral IFN or Topical TLR7 Agonist Promote Vaccine-induced T Cell Infiltration of Melanoma Metastases
    Tran, Christine A.
    Lynch, Kevin T.
    Meneveau, Max O.
    Olson, Walter C.
    Smith, Kelly T.
    Bryant, Jennifer L.
    Slingluff, Craig L.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 510 - 510
  • [2] PD-1 Immune Checkpoint Blockade Promotes Therapeutic Cancer Vaccine to Eradicate Lung Cancer
    Kadam, Pournima
    Sharma, Sherven
    VACCINES, 2020, 8 (02) : 1 - 13
  • [3] Enhancement of Vaccine-Induced T-Cell Responses by PD-L1 Blockade in Calves
    Okagawa, Tomohiro
    Konnai, Satoru
    Nakamura, Hayato
    Ganbaatar, Otgontuya
    Sajiki, Yamato
    Watari, Kei
    Noda, Haruka
    Honma, Mitsuru
    Kato, Yukinari
    Suzuki, Yasuhiko
    Maekawa, Naoya
    Murata, Shiro
    Ohashi, Kazuhiko
    VACCINES, 2023, 11 (03)
  • [4] Intratumoral IFN-γ or topical TLR7 agonist promotes infiltration of melanoma metastases by T lymphocytes expanded in the blood after cancer vaccine
    Tran, Christine A.
    Lynch, Kevin T.
    Meneveau, Max O.
    Katyal, Priya
    Olson, Walter C.
    Slingluff Jr, Craig L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (02)
  • [5] Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases
    Ileana S. Mauldin
    Nolan A. Wages
    Anne M. Stowman
    Ena Wang
    Walter C. Olson
    Donna H. Deacon
    Kelly T. Smith
    Nadedja Galeassi
    Jessica E. Teague
    Mark E. Smolkin
    Kimberly A. Chianese‐Bullock
    Rachael A. Clark
    Gina R. Petroni
    Francesco M. Marincola
    David W. Mullins
    Craig L. Slingluff
    Cancer Immunology, Immunotherapy, 2016, 65 : 1201 - 1212
  • [6] Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases
    Mauldin, Ileana S.
    Wages, Nolan A.
    Stowman, Anne M.
    Wang, Ena
    Olson, Walter C.
    Deacon, Donna H.
    Smith, Kelly T.
    Galeassi, Nadedja
    Teague, Jessica E.
    Smolkin, Mark E.
    Chianese-Bullock, Kimberly A.
    Clark, Rachael A.
    Petroni, Gina R.
    Marincola, Francesco M.
    Mullins, David W.
    Slingluff, Craig L., Jr.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (10) : 1201 - 1212
  • [7] PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
    Soares, Kevin C.
    Rucki, Agnieszka A.
    Wu, Annie A.
    Olino, Kelly
    Xiao, Qian
    Chai, Yi
    Wamwea, Anthony
    Bigelow, Elaine
    Lutz, Eric
    Liu, Linda
    Yao, Sheng
    Anders, Robert A.
    Laheru, Daniel
    Wolfgang, Christopher L.
    Edil, Barish H.
    Schulick, Richard D.
    Jaffee, Elizabeth M.
    Zheng, Lei
    JOURNAL OF IMMUNOTHERAPY, 2015, 38 (01) : 1 - 11
  • [8] Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma
    Chakraborty, NG
    Chattopadhyay, S
    Mehrotra, S
    Chhabra, A
    Mukherji, B
    HUMAN IMMUNOLOGY, 2004, 65 (08) : 794 - 802
  • [9] PD-1 regulates size, function and duration of a vaccine-induced CD8+ T cell response
    Kuhlmann, K.
    Tartz, S.
    Mittruecker, H. W.
    Jacobs, T.
    IMMUNOLOGY, 2012, 137 : 23 - 23
  • [10] Effective personalized neoantigen vaccine plus anti-PD-1 in a PD-1 blockade-resistant lung cancer patient
    Gao, Song
    Wang, Jiaqian
    Zhu, Zhongzheng
    Fang, Juemin
    Zhao, Yu
    Liu, Zhuqing
    Qin, Huanlong
    Wei, Yuquan
    Xu, Heng
    Dan, Xu
    Yang, Li
    Xu, Qing
    IMMUNOTHERAPY, 2023, 15 (02) : 57 - 70
12345